These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26249173)

  • 1. CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer.
    Zhang Q; Qin J; Zhong L; Gong L; Zhang B; Zhang Y; Gao WQ
    Cancer Res; 2015 Oct; 75(20):4312-21. PubMed ID: 26249173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCL2 conditionally determines CCL22-dependent Th2-accumulation during TGF-β-induced breast cancer progression.
    Mandal PK; Biswas S; Mandal G; Purohit S; Gupta A; Majumdar Giri A; Roy Chowdhury S; Bhattacharyya A
    Immunobiology; 2018 Feb; 223(2):151-161. PubMed ID: 29107385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal CCL5 Promotes Breast Cancer Progression by Interacting with CCR3 in Tumor Cells.
    Yamaguchi M; Takagi K; Narita K; Miki Y; Onodera Y; Miyashita M; Sasano H; Suzuki T
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer stem-like cells differentiate into endothelial cells and participate in tumor angiogenesis through autocrine CCL5 signaling.
    Tang S; Xiang T; Huang S; Zhou J; Wang Z; Xie R; Long H; Zhu B
    Cancer Lett; 2016 Jun; 376(1):137-47. PubMed ID: 27033454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.
    Brauß TF; Winslow S; Lampe S; Scholz A; Weigert A; Dehne N; von Stedingk K; Schmid T; Brüne B
    Mol Carcinog; 2017 Dec; 56(12):2620-2629. PubMed ID: 28731284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential to target CCL5/CCR5 in breast cancer.
    Velasco-Velázquez M; Xolalpa W; Pestell RG
    Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR5 antagonist blocks metastasis of basal breast cancer cells.
    Velasco-Velázquez M; Jiao X; De La Fuente M; Pestell TG; Ertel A; Lisanti MP; Pestell RG
    Cancer Res; 2012 Aug; 72(15):3839-50. PubMed ID: 22637726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory chemokines CCL2 and CCL5 in breast cancer.
    Soria G; Ben-Baruch A
    Cancer Lett; 2008 Aug; 267(2):271-85. PubMed ID: 18439751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.
    Moeller M; Kershaw MH; Cameron R; Westwood JA; Trapani JA; Smyth MJ; Darcy PK
    Cancer Res; 2007 Dec; 67(23):11428-37. PubMed ID: 18056471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
    Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
    Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophils drive accelerated tumor progression in the collagen-dense mammary tumor microenvironment.
    García-Mendoza MG; Inman DR; Ponik SM; Jeffery JJ; Sheerar DS; Van Doorn RR; Keely PJ
    Breast Cancer Res; 2016 May; 18(1):49. PubMed ID: 27169366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis.
    Gao D; Cazares LH; Fish EN
    BMC Cancer; 2017 Dec; 17(1):834. PubMed ID: 29216863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.
    Gallego-Ortega D; Ledger A; Roden DL; Law AM; Magenau A; Kikhtyak Z; Cho C; Allerdice SL; Lee HJ; Valdes-Mora F; Herrmann D; Salomon R; Young AI; Lee BY; Sergio CM; Kaplan W; Piggin C; Conway JR; Rabinovich B; Millar EK; Oakes SR; Chtanova T; Swarbrick A; Naylor MJ; O'Toole S; Green AR; Timpson P; Gee JM; Ellis IO; Clark SJ; Ormandy CJ
    PLoS Biol; 2015 Dec; 13(12):e1002330. PubMed ID: 26717410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene.
    Ankathatti Munegowda M; Xu S; Freywald A; Xiang J
    Mol Immunol; 2012 Jun; 51(2):143-9. PubMed ID: 22424785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells.
    Yamamoto J; Adachi Y; Onoue Y; Adachi YS; Okabe Y; Itazawa T; Toyoda M; Seki T; Morohashi M; Matsushima K; Miyawaki T
    J Leukoc Biol; 2000 Oct; 68(4):568-74. PubMed ID: 11037980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloid STAT3 Promotes Lung Tumorigenesis by Transforming Tumor Immunosurveillance into Tumor-Promoting Inflammation.
    Zhou J; Qu Z; Sun F; Han L; Li L; Yan S; Stabile LP; Chen LF; Siegfried JM; Xiao G
    Cancer Immunol Res; 2017 Mar; 5(3):257-268. PubMed ID: 28108629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granulocyte macrophage colony-stimulating factor-driven respiratory mucosal sensitization induces Th2 differentiation and function independently of interleukin-4.
    Ritz SA; Cundall MJ; Gajewska BU; Alvarez D; Gutierrez-Ramos JC; Coyle AJ; McKenzie AN; Stämpfli MR; Jordana M
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):428-35. PubMed ID: 12356576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells.
    Zhang Y; Lv D; Kim HJ; Kurt RA; Bu W; Li Y; Ma X
    Cell Res; 2013 Mar; 23(3):394-408. PubMed ID: 23266888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The β-catenin signaling pathway induces aggressive potential in breast cancer by up-regulating the chemokine CCL5.
    Yasuhara R; Irié T; Suzuki K; Sawada T; Miwa N; Sasaki A; Tsunoda Y; Nakamura S; Mishima K
    Exp Cell Res; 2015 Oct; 338(1):22-31. PubMed ID: 26363360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.